DOK1 Mediates SHP-2 Binding to the αVβ3 Integrin and Thereby Regulates Insulin-like Growth Factor I Signaling in Cultured Vascular Smooth Muscle Cells
Open Access
- 1 February 2005
- journal article
- Published by Elsevier
- Vol. 280 (5) , 3151-3158
- https://doi.org/10.1074/jbc.m411035200
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by β1 integrinsThe Journal of cell biology, 2004
- SHP‐2 regulates the phosphatidylinositide 3′‐kinase/Akt pathway and suppresses caspase 3‐mediated apoptosisJournal of Cellular Physiology, 2003
- The Association between Integrin-associated Protein and SHPS-1 Regulates Insulin-like Growth Factor-I Receptor Signaling in Vascular Smooth Muscle CellsMolecular Biology of the Cell, 2003
- A Chemical Genetic Screen for Direct v-Src Substrates Reveals Ordered Assembly of a Retrograde Signaling PathwayChemistry & Biology, 2002
- Domain-dependent Function of the rasGAP-binding Protein p62Dok in Cell SignalingJournal of Biological Chemistry, 2001
- The Shp-2 Tyrosine Phosphatase Has Opposite Effects in Mediating the Activation of Extracellular Signal-regulated and c-Jun NH2-terminal Mitogen-activated Protein KinasesJournal of Biological Chemistry, 1998
- Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cellsEndocrinology, 1995
- Insulin-like growth factor-1 stimulation of cells induces formation of complexes containing phosphatidylinositol-3-kinase, guanosine triphosphatase-activating protein (GAP), and p62 GAP-associated proteinEndocrinology, 1995
- Association of insulin receptor substrate-1 with integrinsScience, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993